Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.5 GBX | -1.04% | -1.04% | -9.52% |
Mar. 26 | Scancell doses first patient in melanoma-focused trials | AN |
Mar. 14 | Scancell Holdings plc Appoints Sath Nirmalananthan to the Board | CI |
Evolution of the average Target Price on Scancell Holdings plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCLP Stock
- Consensus Scancell Holdings plc